Skip to main content

Advertisement

Right atrial and SVC infiltrating mass-the entity of infiltrating lipoma

Article metrics

Abstract

Background

Cardiac lipomas are rare benign primary cardiac tumours primarily composed of mature adipocytes. They are usually well defined, encapsulated masses, but rarely demonstrate malignant characteristics by infiltrating the myocardium. This causes diagnostic uncertainty as it becomes a priority to rule out primary malignant cardiac tumours such as sarcoma which often carry a poor prognosis.

Case Report

A 61 year old female presenting with chest pain was found to have an infiltrating right atrial hypertrophic mass. Mutli-disciplinary team (MDT) discussions along with the presence of symptoms and likelihood of malignancy led to the recommendations for surgery.

Intraoperatively this involved the right pulmonary veins and superior vena cava (SVC). The mass was resected with good margins and reconstruction of the right atrium, pulmonary veins and SVC was done using porcine pericardial patch. The patient made a good postoperative recovery and was discharged home in sinus rhythm with no significant valvular lesions. This was further confirmed at 6 month follow up. Final histology was that of infiltrating lipoma.

Conclusions

In this rare case of infiltrating cardiac lipoma in a relatively young patient, the diagnostic uncertainty despite multimodal imaging meant surgery was indicated due to the high suspicion of cancer. Even in benign cases, fatty infiltration can lead to conduction defects and embolisation. Technical difficulties in sectioning these specimens is caused by intra-tumour variability and current recommendations are for excision biopsy, for best characterisation.

The management of these patients requires an MDT with Cardiac surgery being a safe approach providing definitive management.

Background

Primary cardiac neoplasms are rare with post-mortem incidence estimates ranging from 0.001% to 0.03% [1]. Three quarters of these lesions are benign with most being cardiac myxomas. Other benign lesions include tumours of adipose tissue such as lipoma and lipomatous hypertrophy which together account for 6-10% cases. Cardiac lipomas are well defined encapsulated benign masses composed predominantly of mature adipocytes. They can however infiltrate into the underlying myocardium in which case they are known as infiltrating cardiac lipoma [2]. Cardiac lipomas are most frequently observed in the right atrium and left ventricle however they can arise in numerous locations within the heart with 50% being subendocardial, 25% pericardial and 25% intramyocardial [3, 4]. They can occur at any age with no gender predisposition reported [3]. Cardiac lipomas are usually incidental findings remaining asymptomatic however they can result in syncope, embolisation and obstruction of blood flow within the chambers or the coronary arteries due to mass effect.

Furthermore, myocardial infiltration can result in conduction defects causing rhythm disturbances [5].

Case Report

A 61 year old female with a background of asthma, hypertension and previous smoking, presented with chest pain and was found to have an infiltrating right atrial hypertrophic mass suspicious for sarcoma on transthoracic echocardiography and cardiac MRI.

Coronary angiogram showed no flow-limiting lesions and cardiac echocardiogram showed restrictive changes with epicardial thickening in the right atrium and around the superior vena cava (SVC). Cardiac computed tomography (CT)(Fig. 1) and magnetic resonance imaging (MRI)(Figs. 2 and 3) revealed an infiltrative fatty lesion encased in the SVC, invading into the right atrium.

Fig. 1
figure1

Transverse plane contrast CT thorax showing right atrial mass

Fig. 2
figure2

Transverse T1 weighted Cardiac MRI showing right atrial mass

Fig. 3
figure3

Transverse T2 weighted Cardiac MRI showing right atrial mass

Following multi-disciplinary team (MDT), patient and family discussions, the patient consented to surgery.

Intraoperatively, there was a fatty infiltrating mass involving the right atrium, right superior pulmonary vein and SVC. The patient was placed onto cardiopulmonary bypass using bicaval cannulation with the SVC cannulated as distal as possible. The mass was resected with good margins. Right atrium, pulmonary veins and proximal SVC were reconstructed using porcine pericardium.

Tissue was sent for histology, Sections showed lipomatous tumour entrapping myocardial cells, composed of lobules of mature adipocytes and very thin fibro-vascular septa. No significant cytological atypia was observed. On molecular genetic testing, MDM2 gene amplification was negative by interphase FISH ruling out a malignant liposarcoma. A diagnosis of infiltrating lipoma involving the right atrium was established.

The patient made a good postoperative recovery and was discharged in sinus rhythm with no significant valvular lesions. This was confirmed at six months review.

Discussion and Conclusions

Infiltrating cardiac lipoma provides a diagnostic challenge. It cannot be distinguished from primary malignant cardiac lesions such as liposarcoma based on clinical presentation or non- invasive diagnostic modalities. Cardiac liposarcomas are aggressive malignant mesenchymal neoplasms which carry poor prognosis and hence represent important differentials to be ruled out [6]. Intra-cavitary lipomas usually present as homogenous hyperechoic masses on echocardiography however these findings are not diagnostic and hence cannot be utilised to conclusively distinguish cardiac lipomas from cardiac liposarcomas [7]. Both cardiac computerized tomography (CT) and cardiac MRI can identify fat and hence aid tissue characterisation. Studies have shown cardiac MRI to be the gold standard diagnostic imaging modality for cardiac lipoma. This typically shows a high signal intensity on T1 weighted images which decreases drastically with fat suppression signals [7, 8]. Unfortunately, even MRI has limited sensitivity, helping to distinguish 69% of cases in the setting of well differentiated liposarcoma [9]. This uncertainty was demonstrated when assessing the MRI of our patient where in light of the fatty, infiltrative nature of the lesion, we could not conclusively rule out liposarcoma. Conclusive diagnosis requires histological analysis of tissue specimen. Furthermore, due to sampling errors and intra-tumour variability, accurate analysis and best tissue characterisation requires excision biopsy [10].

In a literature review, we found seven cases of infiltrating cardiac lipoma. Three of these cases describe lipomas originating on the epicardial aspect infiltrating into the underlying ventricular myocardium one of which reported multiple infiltrating lipomas [11,12,13]. The remaining four cases report intercavitary tumours. Of these, one case reported right ventricular lipoma involving the interatrial septum and tricuspid valve [2], one case reported bi-ventricular tumour invading the underlying myocardium [14], one was that of a left atrial mass extending to the ventricles [15] and one case reported an infiltrating lipoma involving the mitral valve [16]. Presenting complaints in these reports included palpitations, presyncope, paroxysms of tachycardia, collapse, dyspnoea and anasarca. Surgical resection of the tumour was reported and advocated in five of the cases. Of the remaining two cases, one described a post mortem case [11] while the other reported extensive recurrent infiltrating lipoma where complete resection was not originally possible due to the close proximity of vital structures [14].

Due to the rarity of cardiac lipomas, there have been no large cohort studies or randomised trials to produce guidelines on treatment. Prompt surgical management can however lead to complete cure resulting in excellent long-term prognosis. Even if benign, infiltrating cardiac lipomas can manifest in fatal clinical sequelae such as arrythmias and heart failure. The management of infiltrating lipomas provides for diagnostic challenges and hence requires an MDT approach and comprehensive patient counselling. We have demonstrated cardiac surgery in this setting is safe and provides good medium to long-term results.

Availability of data and materials

Not applicable

Abbreviations

CT:

Computed Tomography

FISH:

Fluorescence in situ hybridization

MDT:

Multi-Disciplinary Team

MRI:

Magnetic Resonance Imaging

SVC:

Superior Vena Cava

References

  1. 1.

    Reynen K. Cardiac Myxomas. N Engl J Med. 1995;333(24):1610–7. Cited 2019 Jan 27; Available from. https://doi.org/10.1056/NEJM199512143332407.

  2. 2.

    Fang L, He L, Chen Y, Xie M, Wang J. Infiltrating Lipoma of the Right Ventricle Involving the Interventricular Septum and Tricuspid Valve: Report of a Rare Case and Literature Review. Medicine (Baltimore). 2016;95(3):e2561 Cited 2019 Jan 27; Available from: http://www.ncbi.nlm.nih.gov/pubmed/26817909.

  3. 3.

    da Silveira WL, Nery MW, Soares EC, Leite AF, Nazzetta H, Batista MA, et al. Lipoma of the right atrium. Arq Bras Cardiol. 2001;77(4):361–8 Cited 2019 Jan 27; Available from: http://www.ncbi.nlm.nih.gov/pubmed/11733805.

  4. 4.

    Sankar NM, Thiruchelvam T, Thirunavukkaarasu K, Pang K, Hanna WM. Symptomatic lipoma in the right atrial free wall. A case report. Texas Hear Inst J. 1998;25(2):152–4 Cited 2019 Jan 27; Available from: http://www.ncbi.nlm.nih.gov/pubmed/9654663.

  5. 5.

    Ganame J, Wright J, Bogaert J. Cardiac lipoma diagnosed by cardiac magnetic resonance imaging. Eur Heart J. 2008;29(6):697. Cited 2019 Jan 27; Available from. https://doi.org/10.1093/eurheartj/ehm476.

  6. 6.

    Kong F, Zhang W, Guo Q. Multiple well- differentiated cardiac liposarcoma with a concomitant myocardial lipoma: A case report. Mol Clin Oncol. 2018;9(6):617–21. Cited 2019 Jan 27; Available from. https://doi.org/10.3892/mco.2018.1741.

  7. 7.

    Ragland MM, Tak T. The role of echocardiography in diagnosing space-occupying lesions of the heart. Clin Med Res. 2006;4(1):22–32 Cited 2019 Jan 27; Available from: http://www.ncbi.nlm.nih.gov/pubmed/16595790.

  8. 8.

    van Beek EJR, Stolpen AH, Khanna G, Thompson BH. CT and MRI of pericardial and cardiac neoplastic disease. Cancer Imaging. 2007;7(1):19–26 Cited 2019 Jan 27; Available from: http://www.ncbi.nlm.nih.gov/pubmed/17339142.

  9. 9.

    O’Donnell PW, Griffin AM, Eward WC, Sternheim A, White LM, Wunder JS, et al. Can Experienced Observers Differentiate between Lipoma and Well-Differentiated Liposarcoma Using Only MRI? Sarcoma. 2013;2013:982784 Cited 2019 Jan 27; Available from: http://www.ncbi.nlm.nih.gov/pubmed/24385845.

  10. 10.

    Steger CM. Primary liposarcoma of the heart. BMJ Case Rep. 2011; Cited 2019 Jan 27; 2011. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22696697.

  11. 11.

    Li J, Ho SY, Becker AE, Jones H. Multiple Cardiac Lipomas and Sudden Death: A Case Report and Literature Review. Cardiovasc Pathol. 1998;7(1):51–5 Cited 2019 Feb 12; Available from: http://linkinghub.elsevier.com/retrieve/pii/S1054880797000586.

  12. 12.

    Schrepfer S, Deuse T, Detter C, Treede H, Koops A, Boehm DH, et al. Successful resection of a symptomatic right ventricular lipoma. Ann Thorac Surg. 2003;76(4):1305–7 Cited 2019 Feb 12; Available from: http://linkinghub.elsevier.com/retrieve/pii/S000349750300523X.

  13. 13.

    Shenthar J, Sharma R, Rai MK, Simha P. Infiltrating cardiac lipoma presenting as ventricular tachycardia in a young adult. Indian Heart J. 2015;67(4):359–61 Cited 2019 Feb 12; Available from: http://www.ncbi.nlm.nih.gov/pubmed/26304569.

  14. 14.

    Peters CM, Kalra N, Sorrell VL. Extensive recurrent cardiac lipoma. J Cardiovasc Comput Tomogr. 2009;3(4):282–3 Cited 2019 Feb 12; Available from: https://linkinghub.elsevier.com/retrieve/pii/S1934592509001488.

  15. 15.

    Vaughan CJ, Weremowicz S, Goldstein MM, Casey M, Hart M, Hahn RT, et al. A t (2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis. Genes Chromosomes Cancer. 2000;28(2):133–7 Cited 2019 Feb 12; Available from: http://www.ncbi.nlm.nih.gov/pubmed/10824997.

  16. 16.

    Anderson DR, Gray MR. Mitral incompetence associated with lipoma infiltrating the mitral valve. Br Heart J. 1988;60(2):169–71 Cited 2019 Feb 12; Available from: http://www.ncbi.nlm.nih.gov/pubmed/3415877.

Download references

Acknowledgements

Not applicable

Funding

The authors received no funding for this study.

Author information

OAS and AB wrote the manuscript. MK was the lead surgeon with TV and AB assisting in the operation. All authors revised and approved the final written manuscript.

Correspondence to Abdul Badran.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Informed consent gained from patient for publication of this report.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shah, O.A., Badran, A., Kaarne, M. et al. Right atrial and SVC infiltrating mass-the entity of infiltrating lipoma. J Cardiothorac Surg 14, 210 (2019) doi:10.1186/s13019-019-1015-7

Download citation

Keywords

  • Infiltrating cardiac lipoma
  • Cardiac leiomyosarcoma
  • Right atrial tumour